EU Funds $8M Personalized Breast Cancer Biomarker Project | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The European Union has funded a new €6 million ($8 million) project led by the Charité - Universitätsmedizin Berlin, the medical school for Humboldt University and the Free University of Berlin, that seeks to develop new biomarker tests for tailoring treatments for breast cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.